Article

Comprehensive evaluation of AT(N) imaging biomarkers for predicting cognition

2024-11-27

Abstract excerpt

<h4>Background and Objectives</h4> Imaging biomarkers enable in vivo quantification of amyloid, tau, and neurogenerative pathologies that develop in Alzheimer’s Disease (AD). Interest in imaging biomarkers has led to a wide variety of biomarker definitions, some of which potentially offer less predictive value than others. We aimed to assess how different operationalizations of AD imaging biomarkers affect predict...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2bb4795b-7eae-516a-9ff8-f37f0cc0850c
DOI: 10.1101/2024.11.25.24317943

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Comprehensive evaluation of AT(N) imaging biomarkers for predicting cognitionDOI 10.1101/2024.11.25.24317943Read

Standardized Comparison of Clinical, Cognitive, Genetic, Neuroimaging, and Fluid Biomarkers for Predicting 24-Month Progression from Mild Cognitive Impairment to Alzheimer’s DiseaseSemantic proximity Read

Predicting Autopsy-Confirmed Neuropathology across Clinical, Neuroimaging, and CSF Biomarkers using Machine LearningSemantic proximity Read

Integrating Machine Learning Pipelines for Multimodal Biomarker Prediction in Alzheimer’s and Parkinson’s Disease: A Component of the Neurodiagnoses FrameworkSemantic proximity Read

Multimodal Imaging and Logistic Weighted Cognitive Scores for Classification of MCI, AD, and FTD SubtypesSemantic proximity Read

Diagnosis and Prognosis Using Machine Learning Trained on Brain Morphometry and White Matter ConnectomesSemantic proximity Read

A unified model for staging amyloid and tau pathology in Alzheimer’s diseaseSemantic proximity Read

Prediction of future Alzheimer’s disease dementia using plasma phospho-tau combined with other accessible measuresSemantic proximity Read

Optimal Combinations of Biomarkers to Determine AT(N) in the Alzheimer’s Disease Semantic proximity Read

Developing multifactorial dementia prediction models using clinical variables from cohorts in the US and AustraliaSemantic proximity Read

Soluble Amyloid-Beta Isoforms Predict Downstream Alzheimer’s Disease PathologySemantic proximity Read

Plasma biomarker levels and cognitive decline in a heterogenous community-based cohort with multiple comorbiditiesSemantic proximity Read

Screening for early-stage Alzheimer’s disease using optimized feature sets and machine learningSemantic proximity Read